Comparative Study
[Action of an anti-viral on the Australia antigen in patients with hepatitis A virus and in healthy carriers]
[Article in
Portuguese]
- PMID: 97122
Item in Clipboard
Comparative Study
[Action of an anti-viral on the Australia antigen in patients with hepatitis A virus and in healthy carriers]
[Article in
Portuguese]
G E N.
1977 Jan-Mar.
Abstract
Patients with positive serum HBAg reactions were treated with Viramid (1-beta-D-ribofuranozyl-1, 2, 4-triazol-3-carboxamide) a new anti-viral drug. Of the patients involved in this study, 5 had chronic hepatitis or prolonged hepatitis and 12 were healthy HBAg carriers. Results obtained suggest that the drug had some action on serum HBAg titres with a decrease or negativation of HBAg serum titres in peripheric blood, the evaluation of which was immediately seen by employing the counterimmune electrophoresis technique.
Similar articles
-
[Action of 1-beta-D-ribofuranosyl, 1,2,4-triazol-3-carboxamide on the treatment of acute viral hepatitis].AMB Rev Assoc Med Bras. 1974 Nov;20(11):386-90. AMB Rev Assoc Med Bras. 1974. PMID: 4615344 Clinical Trial. Portuguese. No abstract available.
-
Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.Chemotherapy. 2007;53(6):402-6. doi: 10.1159/000109770. Epub 2007 Oct 12. Chemotherapy. 2007. PMID: 17934260
-
Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.Jpn J Infect Dis. 2007 Feb;60(1):29-32. Jpn J Infect Dis. 2007. PMID: 17314422
-
Ribavirin: an antiviral agent.Pharmacol Ther. 1979;6(1):123-46. doi: 10.1016/0163-7258(79)90058-5. Pharmacol Ther. 1979. PMID: 390559 Review. No abstract available.
-
Viral hepatitis in children.Adv Exp Med Biol. 2004;549:83-90. doi: 10.1007/978-1-4419-8993-2_12. Adv Exp Med Biol. 2004. PMID: 15250519 Review. No abstract available.